The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Patheon Nv | CMN | N6865W105 | 3 | 100 | SH | SOLE | N/A | 100 | 0 | 0 | |
Poseidon Concepts Corp | CMN | 73731R103 | 0 | 19,900 | SH | SOLE | N/A | 19,900 | 0 | 0 | |
Tobira Therapeutics In Contra Cusip Dummy | CMN | 888CVR990 | 0 | 405 | SH | SOLE | N/A | 405 | 0 | 0 | |
Syneron Medical Ltd | CMN | M87245102 | 30 | 2,738 | SH | SOLE | N/A | 2,738 | 0 | 0 |